Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$11,851,002
+$535,386 QoQ
Shares Held
46,663
+0.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
5.93%
of 13F equity value
Holder Rank
#1,012
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Capital Management holds $23,776,064 across 8 Drug Manufacturers - General names. JNJ ranks #1 (49.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
46,663 | $11,851,002 | |
| 2 | ABBV |
AbbVie Inc.
|
25,101 | $6,316,415 | |
| 3 | MRK |
Merck & Co., Inc.
|
38,583 | $4,957,915 | |
| 4 | PFE |
Pfizer Inc
|
13,473 | $324,429 | |
| 5 | AMGN |
Amgen Inc
|
409 | $148,107 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,500 | $86,430 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
512 | $64,686 | |
| 8 | OGN |
Organon & Co.
|
2,000 | $27,080 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,851,002 | 46,663 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $11,315,616 | 46,292 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $9,738,446 | 47,057 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $8,762,207 | 47,256 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,229,657 | 47,330 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $5,796,108 | 34,950 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $5,039,862 | 34,849 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $5,754,426 | 35,508 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,170,410 | 35,375 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $2,965,113 | 18,744 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $2,938,091 | 18,745 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $2,974,357 | 19,097 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $3,021,898 | 18,257 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $2,945,465 | 19,003 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,355,996 | 18,998 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $3,103,513 | 18,998 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,401,979 | 19,165 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $3,531,839 | 19,928 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $3,409,082 | 19,928 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $3,216,757 | 19,918 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,431,863 | 20,832 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,431,956 | 20,882 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $3,290,343 | 20,907 | Shares | Sole | 2021-01-12 | |
| 2020-03-31 | $1,994,356 | 15,209 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||